Aurinia Pharmaceuticals Inc.·4

Nov 14, 4:31 PM ET

Habig Scott Michael 4

4 · Aurinia Pharmaceuticals Inc. · Filed Nov 14, 2022

Insider Transaction Report

Form 4
Period: 2022-11-09
Habig Scott Michael
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2022-11-09$5.01/sh+5,000$25,0755,000 total

Documents

1 file
  • 4
    wf-form4_166846148591533.xmlPrimary

    FORM 4